Hyderabad’s Shanchol Cholera Vaccine Re-Approved By WHO To Boost Global Supply
Hyderabad, Oct 9 (Maxim News) Reinforcing its title as the vaccine capital of India, a major pharma company from Hyderabad is set to re-energise the global supply of the life-saving oral cholera vaccine.
Shanchol, the oral cholera vaccine originally developed by Hyderabad-based Shantha Biotechnics, has received prequalification from the World Health Organization (WHO), enabling global procurement agencies such as UNICEF, Gavi and PAHO to source the vaccine for use in countries where cholera remains a major public health challenge, a statement here on Thursday said.
“Shanchol was conceived as an affordable and accessible solution for countries facing repeated cholera outbreaks. The WHO prequalification of the vaccine carries forward that founding mission,” said Dr K I Varaprasad Reddy, Founder of Shantha Biotechnics.
Over the years, close to 40 million doses of Shanchol have been supplied worldwide through UNICEF-led vaccination campaigns. After production was paused under its former ownership, GCBC Vaccines Pvt Ltd (formerly Shantha) resumed manufacturing, with WHO conducting an on-site inspection and transferring the prequalification.
Shanchol remains the only oral cholera vaccine manufactured in India with WHO prequalification, underscoring India’s key role in ensuring the continuity of global supply.
“As part of the founding family of Gland Pharma, I have seen how world-class sterile manufacturing from India can transform global healthcare. By resuming production of Shanchol, we are bringing the same rigour and reliability to ensure this life-saving vaccine remains available worldwide,” said Dr Ravi Penmetsa, Managing Director, GCBC Vaccines Pvt Ltd.
“This milestone underscores Shantha’s renewed commitment to global health. Our focus is on ensuring that vaccines like Shanchol reach the countries that need them most, reliably and affordably. At the same time, we are working to bring other affordable and innovative vaccines from our pipeline to global markets, continuing Shantha’s tradition of expanding access to life-saving immunisation,” said Dr Vishy Chebrol, Executive Director, GCBC Vaccines Pvt Ltd. (Maxim News)
Next Story:
Intermediate Girl Died Under Suspicious Circumstances
![Intermediate Girl Died Under Suspicious Circumstances]()
Intermediate student found dead under suspicious circumstances in Karimnagar’s Shivarampally. Police launch probe into the 17-year-old’s death.
Donald Trump Cuts Tariffs On Food Imports
![Donald Trump Cuts Tariffs On Food Imports]()
Trump cuts tariffs on food imports to address affordability. India’s mango, pomegranate, and tea exports expected to see major gains.
Three Women Injured As Car Overturns On PVNR Expressway
![Three Women Injured As Car Overturns On PVNR Expressway]()
Three women injured after a car overturned on PVNR Expressway near Attapur. Police suspect overspeeding caused the accident; traffic disrupted.
Telangana Records Single-Digit Temperatures
![Telangana Records Single-Digit Temperatures]()
Telangana records single-digit winter temperatures as cold intensifies. Lowest at 8.1°C in Kohir and Yalal; IMD predicts more chill ahead.
12 Passengers Injured As TGSRTC Bus Hits Lorry
![12 Passengers Injured As TGSRTC Bus Hits Lorry]()
12 passengers injured after TGSRTC bus from Nizamabad to Warangal hit a lorry near Manakondur. Police suspect over-speeding as cause.
Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe. Click to follow Indtoday’s Facebook page, Twitter, and Instagram. For all the latest Hyderabad News updates
